Skip to main content
. 2021 Feb 17;65(3):e01858-20. doi: 10.1128/AAC.01858-20

TABLE 2.

Characteristics of transconjugants

Strain Cip concn (µg/liter) na Resistanceb
MLSTc Resistance genes (% identity) Resistance mutations Virulence gene(s) Plasmid replicons Transfer event
Cip Str
SP132 S/R R ST409 ctx-m-1, mdf(A) wt or gyrA S83L gad IncI1 (100%)
SP163 R S ST359 tet(A), mdf(A) gyrA S83L, D87N, parC S80I cba, cma, iroN, iss, lpfA, mchF IncFIB (AP001918), IncFIB (pLF82), IncFIC (FII)
Transconjugants 0 4 R S ST359 tet(A), ctx-m-1, mdf(A) gyrA S83L, D87N, parC S80I cba, cma, gad, iroN, iss, lpfA, mchF IncI1, IncFIB (AP001918), IncFIB (pLF82), IncFIC (FII) SP163 recipient; SP132 donor
5 S S ST11511 tet(A) (99%), ctx-m-1 parC S57T, parE I355T gad IncI1, p0111 Endogenous Tetr recipient; SP132 donor
1 5 S S ST11511 tet(A) (99%), ctx-m-1 parC S57T, parE I355T gad IncI1, p0111 Endogenous Tetr recipient; SP132 donor
17 S S ST48 tet(A), ctx-m-1, mdf(A), aadA5, sul2, dfrA17 No mutations gad IncI1, IncFIB (AP001918), IncFIB (pLF82), IncFII (pHN7A8), p0111 Endogenous Tetr recipient; SP132 donor
12 R S ST359 tet(A), ctx-m-1, mdf(A) gyrA S83L, D87N, parC S80I cba, cma, gad, iroN, iss, lpfA, mchF IncI1, IncFIB (AP001918), IncFIB (pLF82), IncFIC (FII) SP163 recipient; SP132 donor
5 5 S S ST165 tet(A), ctx-m-1, mdf(A) No mutations gad IncI1 Endogenous Tetr recipient; SP132 donor
2 R R ST409 tet(B), ctx-m-1, mdf(A) gyrA S83L, rpsL K43R gad IncI1, IncHI2, IncHI2A SP132 recipient; endogenous Tetr donor
20 2 S S ST165 tet(A), ctx-m-1, mdf(A) No mutations gad IncI1 Endogenous Tetr recipient; SP132 donor
a

n = number of transconjugants.

b

Cip, ciprofloxacin; Str, streptomycin; S, sensitive; R, resistant according to EUCAST breakpoints.

c

MLST is reported according to the Achtman scheme. Identity to the reference is given when <100%.